Haydale (AIM: HAYD), the global technologies and materials group that facilitates the integration of nanomaterials into the next generation of commercial technologies and industrial materials, announces its unaudited interim results for the six months ended 31 December 2016 (the "period").
Post Period End Highlights:
Commenting on the interim results, Ray Gibbs, CEO of Haydale, said:
"This half year has seen the successful acquisition and integration of two businesses that substantially increases our international reach and broadens our speciality nanomaterials offering. These businesses have widened our offering of advanced material products and expertise to include silicon carbide from our US operations, and a range of graphene and other functional inks from the Far East. We still see the composites market as fertile ground for our materials and dispersion know-how to deliver real, enhanced product solutions to the market. Although the Huntsman work has taken more time, they remain committed to launching a graphene adhesive and a thermally enhanced graphene pre preg in the next financial year. In addition, by combining nanomaterials we can create unique property enhancing hybrids that offer high performance electrical conductivity, improved thermal heat management and light-weighting opportunities.
Our market presence is such that we are attracting significant global "best in class" organisations wishing to engage with us to provide engineering solutions for defined commercial needs. The next 12 to 18 months should be an exciting time for the Group, which we believe now has the customer engagement, geographic reach and product know how to create material change in the Group's future revenues."
Caution regarding forward looking statements
Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identiﬁed by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reﬂect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.
A number of factors could cause actual results to differ materially from the results discussed in the forward looking statements including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes, actions by governmental authorities, the availability of capital markets, reliance on key personnel, uninsured and underinsured losses and other factors, many of which are beyond the control of the Company. Although any forward looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions, the Company cannot assure investors that actual results will be consistent with such forward looking statements. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Subject to any continuing obligations under applicable law or any relevant AIM Rule requirements, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.
I am delighted to present the Group's third set of interim results since the Company's AIM IPO in 2014. There have been several key events in the period, not least expanding our international reach and product offering through strategic acquisitions in the USA and Thailand. Both businesses have been successfully integrated into the Group and provide us with routes to geographic markets with a range of novel speciality nanomaterials and products to add to our portfolio of graphene and other carbons. Crucially, their addition allows us to combine our graphene nanomaterials and produce hybrid "masterbatches" as we see this as the optimal way to significantly improve end-product performance and overcome industry's reluctance to handle powders.
With the increase in our international footprint, combined with our current and target customers who typically operate internationally across a variety of sectors, we have started the process of reorganising our operations into two distinct strategic business units.
In the autumn of 2016, we commissioned two plasma reactors sold to Graphit Kropfmühl GmbH, as part of our strategic collaboration and industrial scale up plans to accommodate masterbatch products required initially for our collaboration partners Huntsman and Flowtite. The Group remains on course to install and commission an HT60 plasma reactor into the Thailand Science Park at our Bangkok facility acquired last year by the end of March and we expect this unit to be fully operational within the coming weeks. Once operational, it will service Thai customers and regional projects plus other Far East countries such as Korea and Taiwan. Our sales team in the Far East are making good inroads into customers requiring graphene conductive inks, mainly from our Thailand operation and Taiwanese collaboration.
Strategic Business Units ("SBUs")
Following a period of intense corporate activity, the Group is now established as a global advanced materials business. To exploit this, we are creating two SBUs to focus delivery of next generation products to our customers:
Feeding into each SBU will be dedicated service and support functions, including the plasma functionalisation and nano powders handling capability of our Ammanford and, soon to be operational, Thailand facilities. Other dedicated service units will be added when appropriate.
Resin and Polymer based Composites
The RPC SBU has had a busy and productive period. We continued progressing our self-funded resin project with Huntsman and, as reported in last year's AGM Statement and the February trading update, the customer sampling process with Huntsman for graphene enhanced Araldite® epoxy resin is taking longer than the Group had originally anticipated. As a result, commercial revenues from this agreement are now expected to commence in the second half of the next financial year. The focus of this work remains on the graphene enhanced Araldite® adhesive. The follow-on product, expected to be ready in early 2018, is a thermally conductive graphene pre-preg designed to increase composite throughput by improving epoxy resin systems "cure" time and to manage the exothermic reaction on thick section thermoset mouldings. Improving the speed of production is a major operational driver in the composite industry.
Prior to the recent JEC Composites Show in Paris, on 9 March 2017, Huntsman announced strong initial test results from our graphene enhanced Araldite® resins in thermal management, demonstrating high performance solutions under their theme "Chemistry for Lightweight". Huntsman's target markets range from structural composite parts of transportation interiors, to carbon hybrid composite wheels for automotive and from mass-production to pultrusion solutions. The next key milestone will be for Huntsman to test the market in high-end toughened adhesives and thermally conductive pre-preg systems in the automotive and aerospace markets.
Pleasingly, the Group recently received independently verified results from Haydale developed graphene enhanced epoxy Carbon Fibre pre-pregs ("CFRP") which show superior mechanical performance of up to 20 per cent. when compared to a standard non-graphene enhanced CFRP. This has the potential to be a major industrial breakthrough enabling engineers to design lighter weight structures with the same physical performance. A reduction in the number of layers would not only save significant weight and material usage but also reduce the laminating costs making composite materials and structures more affordable for a range of mass market products, such as composite tooling.
As previously announced, the Group's ongoing project with Flowtite Technology ("Flowtite") on developing a graphene enhanced glass fibre reinforced pipe ("GRP") moves into the development phase with the first production trials now set for April 2017. A period of testing and certification of up to twelve months will then follow the production trials and, if successful, Flowtite expects to launch their new graphene enhanced GRP in the second half of the next financial year.
Since the beginning of the current financial year, the Group has secured grants to develop several next generation commercial products worth in excess of £0.6 million over the next 12-18 months that we see as our future product pipeline. These include: hydrogen storage vessels for Arcola Energy, a leading UK fuel cell system integrator; a novel water filter for the nuclear industry with Sellafield Limited as the commercial partner; and a research and development agreement with the Malaysian Government developing a series of enhanced natural rubber products into graphene composites, aimed at next stage industrial products in Malaysia.
Demonstrating the reach of the composite sector, the UK Space Agency has contracted Haydale to develop advanced composite gas propellant storage tanks for spacecraft and satellites, and; Wave Energy Scotland has contracted Haydale to develop a new rotational moulding, graphene enhanced thermoplastic material to be used in renewable wave energy devices.
Following the commissioning of the pipe testing facility at Loughborough, we are pleased to announce that the Group has secured its first commercial order worth over £90,000 for development of a reinforced thermoplastic pipe to enable the development and approval of graphene enhanced polymer pipes. The initial contract to design, manufacture and test new specification pipes for a leading composite pipes manufacturer, utilising our novel pipe testing facilities is the first phase of a potential significant development contract to certify composite pipes for the oil and gas industry.
As well as the significant next generation of advanced materials that we are developing with tier one partners over the medium to long term, we should not lose sight of the ongoing day-to-day engineering applications composite consulting and testing business, which continues to secure contracts for delivery over the next 24 months. There are a number of projects coming to fruition which we hope will offer substantial future collaboration and revenue potential, and which we will announce as and when appropriate. The expertise, knowledge and knowhow that we have built up within thermoset and thermoplastic sectors continues to provide international cross selling opportunities of the advanced materials being developed within the Group. In particular, the recently announced proposed collaboration with Everpower, (subject to completion of their investment) should provide significant opportunities to develop next generation products for the Chinese market with their extensive in-country presence.
Haydale's newly acquired USA specialty materials business, HTI (formerly ACM), has integrated well into the Group and its trading is in line with management's expectations, delivering sales of approximately almost £0.8 million in the period since its acquisition on 12 October 2016 to 31 December 2016. New business wins include the recently announced four year supply agreement of our proprietary Silicon Carbide ("SiC") whiskers with a leading industrial company manufacturing hard edged cutting tools. The contract specifies an order for the first six months' requirement to be placed in April 2017 and delivered in this financial year. Other smaller but equally important wins have also been achieved, such that the inventory of the SiC fibre is in need of replenishing and that will require a production run starting in April 2017. We still have sufficient inventory to supply nano-sized SiC whiskers for our cutting tool customers, including supplying the initial order under the new four year supply agreement described above.
The acquisition of ACM (now HTI) added a dimension to the Group's nanomaterials product portfolio and an opportunity to cross sell and hybridise its material into our growing customer and contact base. This has already been proven in the Far East with a potential new product launch by a cookware customer currently testing a Haydale developed SiC and graphene hybrid which, if successful could lead to significant orders in subsequent financial years. The global automotive industry represents a sector of extensive opportunity for Haydale's nanomaterials and dispersion know-how where, through our US CEO, Trevor Rudderham, we have extensive connections. Haydale has commenced discussions with a number of major corporations and high profile organisations as a direct result of our product demonstrations at JEC recently, which included the rear diffuser for the BAC Mono and an electrically conductive Airbus aileron using a combination of nanomaterials.
Our patented functionalisation process of nanomaterials, and particularly carbon nanotubes ("CNTs") remains a major added value driver and enabling technology as the market moves towards using hybrid materials where those treated CNTs are mixed with a range of graphenes. The Far East, especially South Korea, is a large producer and user of CNTs and whom we consider lead the world in exploiting commercial opportunities for this material. Our sales office in Seoul is now gathering momentum and we are pleased with progress from this region.
Since our proprietary inks are printed in layers, we consider them to be a part of additive manufacturing, as are the recently launched graphene enhanced 3D PLA printing filaments. After a steady start on conductive inks/pastes Haydale is now starting to see the effects of product development and targeted marketing.
The benefits of grant funded work can be demonstrated at our Ammanford site where two important projects on bio-medical sensors have significantly increased our knowledge and capability in the use of graphene based carbon conductive inks to improve performance metrics. Consequently, the Group remains very active in providing our nano inks into the sensor market which we see as a significant opportunity. The sensor market is a rapidly growing and accessible sector for the Group with significant Far East opportunities under development potentially able to offer relatively short term revenues as well as potentially sustainable longer term revenue returns. In the Far East, we currently have one FDA approved bio-medical ink approved with discussions ongoing with potential customers. Two more bio-medical inks are undergoing FDA approvals, which we are confident of receiving. While the approval process can take time, once approved, printers should start to use them and regular repeat orders are the industry norm. Our ink is also currently under evaluation for a mobile phone application.
In addition, during the period under review, we appointed a sales manager to market and sell Haydale's proprietary graphene enhanced 3D PLA filament, which was launched in Q4 2016. Repeat orders, albeit at a relatively small amount at this early stage, have been received from international distributors and the Group anticipates agreeing additional distribution agreements during 2017. The feedback from distributors and end users has been encouraging, with reference to enhancements in flow speed and post production processing. Other 3D printing developments are under evaluation for future product launches.
We have received some small but important UK Government grants focussed on the use of our base ink. One successful project is the use of an ink system to create a de-icing coating for the aircraft and related industries.
Post period end, Haydale has had two important contract wins. Firstly, the third largest petrochemical company in Thailand, IRPC, has placed a contract with HTT for approximately £70,000. Details of the work remain confidential but project delivery commences in April 2017 and will last nine months. In addition, we are in discussion over our customised nano materials utilising the patented plasma process. Secondly, in early March 2017, the Thai Ministry of Energy, in conjunction with the National Science and Technology Development Agent ("NSTDA"), announced the final successful applicants for the 2017 Energy Storage Research call. Pleasingly, HTT was chosen to produce a printed hybrid functionalised graphene electrode in a supercapacitor, being the only private company to be awarded a grant under this programme. The project starts on 1 April 2017 and will last for 18 months.
Haydale continues to add to its IP base, with both know-how and granted patents. Increasingly, the knowledge based systems in our business have taken on more prominence rather than the process patents. In due course, we anticipate that the know-how and knowledge created will be protected as commercial products are developed such that we secure product patents. It is this knowledge, which is not disclosed, that defines our capability as a leading provider of solutions to our targeted sectors. An example of this migration towards product patents capturing IP know-how is our belief that once a nanomaterial masterbatch is produced, it would be virtually impossible to "reverse engineer" the formulation to determine the functionalisation, mixing and dispersion techniques used to create it.
Meanwhile, the Group has now been advised that the Japanese patent office has allowed us to proceed to grant of patent on our plasma functionalisation process, which we will apply for in early April 2017.
Total unaudited income recognised in the period, which comprised commercial revenues, grants and approximately two and a half months' contribution from ACM (now HTI), was up more than 90 per cent. on the same period last year at £1.5 million (H1-2015: £0.8 million). The Group's forward order book continues to grow, providing improved visibility on future income.
HTI (formerly ACM) contributed just under £0.8 million of revenues during the period at a gross margin of almost 80%., with overall net profit of approximately £0.1 million. Pleasingly, the recently secured new four-year supply agreement should provide additional long term recurring revenues.
Income recognised from grant funded projects fell in the period under review from just under £0.5 million to £0.4 million. This was primarily due to a number of projects moving towards completion in the period and the fact that our contribution in these projects is often front end loaded, being the provision of nanomaterials for dispersion. Nevertheless, the Group sees this small year-on-year reduction being reversed in subsequent periods as the newly secured projects in the period begin to generate income. We remain confident that a number of our funded projects will lead to the launch of a commercial product, incorporating our materials.
As in previous periods, we invested heavily in our own development projects in the six months under review. Total R&D expenditure was almost £0.7 million (H1-2015: £0.5 million), of which £0.55 million was expensed in the period, with £0.15 million being capitalised and amortised over 20 years. Total administration costs during the period amounted to £3.4 million, up from £2.1 million in the corresponding period last year, of which approximately £0.7 million was in relation to the two businesses acquired last year. The balance of the increase in administration costs relates to acquisition costs of just over £0.2 million and the increase in headcount to 50 in the UK. Expenditure on capital equipment during this period was £0.2 million, lower than the £0.5 million spent in H1-2015. Loss after taxation for the period was £2.4 million, up from £1.9 million in the prior period.
The Group's unaudited net assets at 31 December 2016 were £7.8 million (31 December 2015: £8.2 million). The addition of HTI (formerly ACM's) net assets during the period bolstered the Group's fixed assets and inventory balances considerably and also increased the Group's borrowings to £1.6 million at the period end (31 December 2015: £0.4 million). Cash at the period end was £1.1 million. Since the period end, we entered into a subscription agreement for £3.3 million with Everpower, a New York based investment company engaged in investing in leading edge technologies and integrating these technologies into China. In accordance with the agreements with Everpower, we have received approximately £0.3 million of the subscription monies to date, with the balance of £2.9 million due by 31 March 2017.
The two businesses acquired during the period under review were purchased with a mixture of cash, issue of new shares and entering new debt funding facilities. Specifically, it was pleasing to note that the acquisition of ACM (now HTI) was extremely well supported by our shareholders through the 3x oversubscribed open offer which, alongside the placing and subscription, raised approximately £2.6 million.
In December 2016, Tony Belisario retired as Deputy Chairman and stepped down from the Board. On behalf of the Board and as a shareholder, I would like to again thank Tony for his contribution to the Board.
Whilst the last period has been busy, we can see an even greater level of activity now that we have both product sales and a pipeline of engineered applications projects for customers with known requirements starting to generate income across the Group. An unknown factor in all of this is the impact that Everpower will have in the coming months. Even before the final sum of investment has been received (which is due on or before 31 March 2017) they have already requested (and received) product samples to test and promote in China of our SiC and conductive inks, as well as our 3D PLA filaments. Of perhaps greater significance is that they have introduced us as a technology partner to one of the leading Chinese car manufacturers, BYB (Build Your Dreams).
Gearing up for growth and moving from a technically driven organisation to a sales-led business is challenging. It requires focus and dedication with the right people in place and the move to dedicated SBUs. Each unit will be tasked with generating profits and will have a Managing Director, supported by a Sales and Marketing Director and a Technical Director, all with appropriate dedicated service and support teams.
The acquisition of ACM (now HTI) has provided instant product and revenues from which to build upon and the US team are already demonstrating sales wins with other targets identified and being pursued. There are significant opportunities in the nano ceramics market, especially when combining with another material such as graphene. Our Far East inks business has been also winning work and the pipeline of opportunities looks strong, especially in the area of FDA approved inks for bio-medical sensors.
For our composites business, the time taken for large companies to move to product sales has been amply emphasised by the Huntsman work, which is carefully planned to make an impact on a "right first time" basis after focussed Beta testing. The traditional composite based application engineering solutions consultancy of Haydale has been working hard at generating significant work now that the Huntsman R&D project is moving towards a different level. They have several potential contracts under discussion utilising their traditional skills whilst now incorporating property enhancements from using graphene and other nanomaterials at their disposal.
The Haydale team looks forward to a fast moving, income led next 12-18 months.
Chief Executive Officer
22 March 2017
31 Dec 2016
31 Dec 2015
30 Jun 2016
|Research and development expenditure||(548)||(496)||(514)|
|Share based payment expense||(187)||(174)||(326)|
|Other administrative expenses||(3,350)||(2,121)||(5,092)|
|LOSS FROM OPERATIONS||(2,595)||(2,007)||(4,009)|
|LOSS BEFORE TAXATION||(2,624)||(2,014)||(4,023)|
|TOTAL COMPREHENSIVE LOSS FOR THE YEAR FROM CONTINUING OPERATIONS||(2,403)||(1,917)||(3,637)|
|Loss per share attributable to owners of the Parent|
31 Dec 2016
31 Dec 2015
30 Jun 2016
|Property, plant and equipment||5,287||1,782||1,576|
|Cash and bank balances||1,127||5,020||2,862|
|Bank loans – due after one year||1,120||184||104|
|Bank loans – due within one year||506||168||166|
|Trade and other payables||1,131||719||656|
|TOTAL NET ASSETS||7,840||8,204||6,601|
|Capital and reserves attributable to equity holders of the parent|
|Share premium account||15,356||11,859||11,840|
|Share-based payment reserve||843||484||656|
|Retained (deficits) / profits||(8,559)||(4,436)||(6,156)|
|Six months||Six months||Year|
|31 Dec 2016||31 Dec 2015||30 Jun 2016|
|Cash flow from operating activities|
|Loss before taxation||(2,624)||(2,014)||(4,023)|
|Amortisation of intangible assets||35||17||63|
|Depreciation of property, plant and equipment||250||173||370|
|Share-based payment charge||187||174||327|
|(Profit)/Loss on disposal of property, plant and equipment||-||-||(107)|
|Operating cash flow before working capital changes||(2,123)||(1,643)||(3,356)|
|(Increase) / decrease in inventories||152||(120)||(115)|
|(Increase) / decrease in trade and other receivables||(620)||137||(128)|
|Increase / (decrease) in payables and deferred income||170||(499)||187|
|Income tax (paid) / received||54||-||128|
|Net cash flow from operating activities||(2,367)||(2,125)||(3,284)|
|Cash flow used in investing activities|
|Purchase of property, plant and equipment||(225)||(477)||(470)|
|Acquisition of subsidiary||3||4||-||(429)|
|Proceeds from disposal of property, plant and equipment||-||-||207|
|Settlement of deferred consideration||-||-||(350)|
|Net cash flow in investing activities||(221)||(477)||(1,042)|
|Cash flow used in financing activities|
|Proceeds from issue of share capital||2,591||6,038||5,359|
|Share issue costs||(157)||(377)||-|
|New bank loans raised||1,405||-||-|
|Repayments of borrowings||(2,921)||(81)||(162)|
|Net cash flow from financing activities||889||5,573||5,183|
|Effects of exchange rate changes||(36)||-||(44)|
|Net (decrease) / increase in cash and cash equivalents||(1,735)||2,971||813|
|Cash and cash equivalents at beginning of the financial period||2,862||2,049||2,049|
|Cash and cash equivalents at end of the financial period||1,127||5,020||2,862|
|Share Capital||Share premium||Share-based payment reserve||Retained profits||Other reserves||Total|
|At 1 July 2015||229||6,254||329||(2,519)||-||4,293|
|Total comprehensive loss for the period||-||-||-||(1,917)||-||(1,917)|
|Recognition of share-based payments||-||-||174||-||-||174|
|Issue of ordinary share capital||75||5,925||-||-||-||6,000|
|Transaction costs in respect of share issues||-||(377)||-||-||-||(377)|
|At 31 December 2015||305||11,859||484||(4,436)||(8)||8,204|
|Total comprehensive loss for the period||-||-||-||(1,681)||-||(1,681)|
|Recognition of share-based payments||-||-||153||-||-||153|
|Reduction in share premium||-||(19)||19||-||-||0|
|Other comprehensive loss||-||-||-||(39)||8||(31)|
|At 30 June 2016||305||11,840||656||(6,156)||(44)||6,601|
|Total comprehensive loss for the period||-||-||-||(2,403)||-||(2,403)|
|Recognition of share-based payments||-||-||187||-||-||187|
|Issue of ordinary share capital||44||3,673||-||-||-||3,717|
|Transaction costs in respect of share issues||-||(157)||-||-||-||(157)|
|Other Comprehensive Income||-||-||-||-||(227)||(227)|
|At 31 December 2016||349||15,356||843||(8,559)||(149)||7,840|
Equity share capital and share premium
The balance classified as share capital and share premium includes the total net proceeds on issue of the Company's equity share capital, comprising £0.02 ordinary shares. The share premium accounts can only be used for bonus issues, to provide for the premium payable on redemption of debentures or to write off preliminary expenses, or expenses of, or commissions paid on, or discounts allowed on, any issues of shares or debentures of the company.
Share premium account
The share premium account represents the amount received on the issue of ordinary shares in excess of their nominal value and is non-distributable.
Share-based payment reserve
The share-based payment reserve comprises the cumulative expense representing the extent to which the vesting period of share options has expired and management's best estimate of the achievement or otherwise of non-market conditions and the number of equity instruments that will ultimately vest.
The retained profits reserve comprises the cumulative effect of all other net gains, losses and transactions with owners (e.g. dividends) not recognised elsewhere.
The full results including the notes to the financial statements are available in the PDF Download.
Page last updated: 22 March 2017